Surgery and Interventional Science
Athena SWAN Bronze Award Logo


Division of Surgery Away Day 2014

Starts: Sep 18, 2014 9:00:00 AM




The Division offers world class training in a wide range of subjects which include a number of second and third year options for MBBS students, plus a number of iBSC and MSc programmes.

Discover our programmes »



Three major themes define the Division's research interests: Tissue and Energy, Materials and Tissue, and Nanotechnology. All three integrate basic, translational and clinical research through collaborations both within and outside of UCL.

Find out more »


UCL Provost visits Stanmore

The UCL President and Provost, Professor Michael Arthur, visited the Division’s Stanmore campus earlier this month, to meet staff and students from the Institute of Orthopaedics and Musculoskeletal Science (IOMS) and the Royal National Orthopaedic Hospital (RNOH).

Public Engagement: Building Bridges Project - Science Museum 2014

Having recently collaborated with the Science Museum in February this year where she hosted a Nanotechnology workshop at the Science Museum’s Lates event, Melissa Bovis, Research Associate, teamed up with the Museum for a second time this month as part of their Building Bridges scheme.  More...

Novel Randomised Trial in Prostate Cancer awarded St Peters Trust/Royal Free Charity grant

Over 40,000 men are diagnosed with prostate cancer every year in the UK. There is much uncertainty about which treatments might be best for these men, so Level I evidence is often required. Traditionally, Level I evidence comprises a head-to-head randomised controlled trial (RCT) of a new intervention versus placebo in which neither the patient nor the doctor knows who is taking what (‘double-blind’). The treatment allocation is based on chance and the blinding prevents biases. In surgery, this design is not always ethical or practical. This means that both doctor and patient have to be made aware of the treatment received in surgical trials. This causes problems. First, surgeons and patients often have strong - but sometimes misplaced - ideas of what works, so RCTs are difficult to recruit to. Second, this often means patients have to seek out trials, leading to a select group of motivated, commonly more educated and affluent patients participating in trials. Third, patients who take part in a trial may not approve of the treatment they have been allocated by chance and withdraw. These factors have led to the failure of many surgical trials to accrue. This has been particularly highlighted in localised prostate cancer RCTs. In fact, 11 RCTs evaluating different interventions in localised prostate in the last decade have failed to recruit.

Division awarded Athena SWAN Bronze Award

The Division is delighted to announce that it has been awarded an Athena Swan Bronze Award for its efforts in supporting and empowering women within the Division.

Logos Royal Free London - NHS Royal National Orthopaedic Hospital - NHS University College London Hospitals - NHS UCL Institute of Biomedical Engineering NPIMR